Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Nagendran Sukumar | Pres, Head of R, D | S Sale | — | $6.24 | $1.2M | filing |
TAYSHA GENE THERAPIE (TSHA) insider trades
TAYSHA GENE THERAPIE (TSHA) insider trading activity (SEC Form 4). Over the trailing 90 days, TSHA insiders filed 0 purchases totalling $0 and 1 sales totalling $1.2M — net SELLING of $1.2M. Most recent filing: Jul 10, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
1
$1.2M
Net (90d)
-$1.2M
net selling
Most recent
Jul 10, 2026